10x Genomics Denmark ApS: Financial statements 2019
CVR: 40243224
Source: annual report 2019, Danish Business Authority
31/01/2019 – 31/12/2019
10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 552,190 and a net result of DKK 245,383. Equity in the 2019 report amounted to DKK 625,383. The solvency ratio was 82.4%.
- Gross Profit
- DKK 552,190
- Profit/Loss
- DKK 245,383
- Equity
- DKK 625,383
- Total Assets
- DKK 758,954
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of April 2, 2019, Søren Fogh Aagaard has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Søren Nyboe Jakobsen has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Sunil Kumar Saini has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Sebastian Hartmut Springer has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Søren Nyboe Jakobsen is registered as adm. dir. of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS was founded on January 31, 2019.
About 10x Genomics Denmark ApS
10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.